Total en L' Oreal have announced to sell their stake in SNY if the price rebounds. Together they hold almost 25% of the company.
simply not true. All of the major shareholders are still in place. And Warren Buffett is still adding to the position. I made a fairly big analysis of 11 stocks in the pharmaceutical business. Sanofi is very, very cheap from the fundamental analysis point of view. you can check out the whole comparison here. Maybe you will need a translator but you should be fine. ww.aktienanalyse-fundamental.blogspot.comViewed as a whole, the whole pharmaceutical sector is cheap compared to the market, compared to other sectors and also compared by itself.
What is your source?
sny is dead meat w/o lovenox and plavix